《减少通货膨胀法》的保健削减帮助了数百万人,但不均衡的州医疗补助决定使得许多人仍然在为费用而苦苦挣扎。 Inflation Reduction Act health cuts helped millions, but uneven state Medicaid decisions leave many still struggling with costs.

联邦保健规定,包括扩大补贴和根据《降低通货膨胀法》进行医疗保险药品定价改革,降低了数百万美国人的成本,但由于州一级的决定,尤其是关于扩大医疗补助的决定,负担能力仍然不均衡。 Federal health care provisions, including expanded subsidies and Medicare drug pricing reforms from the Inflation Reduction Act, have lowered costs for millions of Americans, but affordability remains uneven due to state-level decisions, particularly regarding Medicaid expansion. 虽然一些州扩大了覆盖率并降低了保险费,但另一些州面临更高的成本和有限的准入,特别是在农村和低收入社区。 While some states see improved coverage and reduced premiums, others face higher costs and limited access, especially in rural and low-income communities. 如果不将关键补贴延长至2025年以后,数百万人可能面临溢价增加,引发政治和政策挑战。 Without extension of key subsidies beyond 2025, millions could face premium increases, sparking political and policy challenges.